Vita 34 AG Stock
Your prediction
Vita 34 AG Stock
A loss of -1.210% shows a downward development for Vita 34 AG.
Criterium "Business model" is seen as the biggest plus for Vita 34 AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vita 34 AG in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vita 34 AG | -1.210% | 9.009% | 7.080% | -30.460% | -7.634% | -70.398% | -65.674% |
| Mediclin AG | 2.840% | 0.714% | 12.800% | -7.237% | 6.015% | -35.909% | -47.290% |
| M1 Kliniken AG | 0.380% | -3.971% | 6.400% | 67.929% | 19.820% | 14.655% | - |
| Capital Senior Living Corp. | 3.420% | 11.852% | 2.027% | 340.876% | 249.133% | -12.717% | -46.340% |
News
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023
EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023
EQS-News: Vita 34 downsizes Management Board until further notice
EQS-News: Vita 34 downsizes Management Board until further notice